Secondary outcomes
PD
ADVERSE EVENTS, SECONDARY
The secondary outcomes were the incidence of treatment-associated mild adverse events, treatment-associated changes in the NAD metabolome in blood and urine, and the change in the overall clinical severity of PD, measured by total MDS-UPDRS.